Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)
China flag China · Delayed Price · Currency is CNY
129.19
-1.69 (-1.29%)
Nov 18, 2026, 2:55 PM CST

SHA:600436 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7,9099,00110,78810,0588,6948,022
Revenue Growth
-19.13%-16.56%7.25%15.70%8.38%23.20%
Gross Profit
2,7803,2704,5994,6953,9594,054
Operating Income
1,4812,1983,4203,2302,8492,748
Net Income
1,3172,1592,9772,7972,4722,432
Earnings Per Share
2.183.584.934.644.104.03
EPS Growth
-45.62%-27.38%6.25%13.17%1.74%45.49%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceutical Manufacturing
4,4155,6634,8023,8133,972
Offset of Business Segment
-1,408----
Other
243.99256.78322.95168.6344.89
Cosmetics Manufacturing
660.09752.07706.76634.3841.35
Pharmaceutical Distribution Industry
5,0904,0844,2054,0593,146
Unallocated Other
-31.8722.3119.5217.29
Total
9,00110,78810,0588,6948,022

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,2262,5485,00810,1738,6987,106
Total Debt
1,0221,0621,1481,1661,109885.21
Net Cash (Debt)
1,2041,4863,8599,0077,5896,220
Net Cash Growth
317.86%-61.50%-57.15%18.67%22.01%39.78%
Net Cash Per Share
1.992.466.3914.9412.5910.31

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,90777.031,3142,2076,873462.27
Capital Expenditures
-586.64-339.8-1,068-141.87-175.37-92.17
Free Cash Flow
1,321-262.77245.412,0656,698370.11
Free Cash Flow Growth
---88.11%-69.17%1709.66%-64.69%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
35.15%36.32%42.63%46.68%45.54%50.53%
Operating Margin
18.73%24.42%31.70%32.11%32.77%34.25%
Pretax Margin
19.05%28.19%32.80%33.49%34.25%35.77%
Profit Margin
16.65%23.98%27.60%27.81%28.44%30.32%
FCF Margin
16.70%-2.92%2.27%20.53%77.04%4.61%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
2.6402.9702.9702.3201.2501.210
Dividend Per Share Growth
-18.01%0%28.02%85.60%3.31%34.44%
Dividend Yield
2.04%1.76%1.39%0.96%0.43%0.28%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
59.2547.1743.4752.1970.39108.45
Forward PE
39.4732.0637.4742.8770.4494.42
P/FCF Ratio
59.78-527.3270.7125.98712.61
PS Ratio
9.9811.3112.0014.5220.0232.88